Microsoft Clinches Major AI Partnership With Haleon as $530 Billion Sell-Off Tests Investor Faith

Haleon adopts Azure and Copilot, plans agentic AI apps. The pact underscores Microsoft's healthcare push amid a historic share sell-off driven by AI spending concerns.

Microsoft has signed a five-year strategic pact with consumer health giant Haleon, positioning its Azure and Copilot platforms at the centre of the company’s digital transformation. The deal arrives at a precarious moment for the tech behemoth, whose shares have been battered by a historic sell-off that erased more than $530 billion in market value in June alone.

Haleon will adopt Microsoft Azure as its primary cloud infrastructure and roll out Microsoft 365 Copilot across its operations. The two companies plan to jointly develop artificial intelligence applications spanning supply chains, marketing, and clinical research. A particular emphasis is being placed on so-called agentic AI systems — intelligent digital assistants designed to autonomously manage complex workflows. The message is clear: enterprise AI is moving beyond chatbots into secure, tightly controlled automation.

For Microsoft, the agreement underscores its ambitions in the highly regulated healthcare sector. The company is simultaneously defending the EU-US Data Privacy Framework before the European Court of Justice, intervening formally in an ongoing case. A stable legal foundation for transatlantic data flows is seen as critical for winning over risk-averse European corporations. The Haleon pact demonstrates that this strategy is delivering results, even as broader market sentiment sours.

That souring has been dramatic. Microsoft shares closed at €326.85 in recent trading, representing a 15% decline over the past 30 days — the worst monthly performance since the 2008 financial crisis. The stock has now fallen roughly 19% since the start of the year, well below its key moving averages. At these levels, Microsoft trades at just 19 times forward earnings, a discount to its ten-year historical average. Analyst Brad Reback of Stifel recently lowered his price target from $415 to $400, citing mounting margin pressure from heavy capital expenditure.

The root of the anxiety is not a product failure or regulatory crackdown. Rather, investors are questioning the enormous spending required to build out AI infrastructure, and whether new AI tools might cannibalise demand for traditional software. The buzz around artificial intelligence is giving way to hard-nosed arithmetic. Microsoft must now demonstrate that its billions in AI outlays will translate into sustainable profit margins, not just top-line growth.

Operationally, the company continues to deliver. Revenue in the last quarter climbed 18% to nearly $83 billion, while operating profit rose 20% to more than $38 billion. The cloud business, led by Azure, expanded 40%. The AI segment alone generated an annualised revenue run rate of $37 billion, more than double the prior year. These numbers are undeniably strong, yet the market is demanding concrete evidence that the returns will justify the spend.

The Haleon partnership provides one such piece of evidence — a real-world deployment of AI at scale within a demanding industry. But with the stock deep in correction territory, Microsoft faces an uphill battle to convince shareholders that the long-term payoff is worth the short-term pain.